Cairo – Mubasher: Glaxo SmithKline posted net losses of EGP 72.91 million in the first quarter of the fiscal year 2015 2016, compared with EGP 77.24 million for the same period of the previous year.
The company succeeded in narrowing its losses for Q1-FY15/16 on the increasing sales.
The drug producer reported net profits of EGP 69.14 million for FY15/16, up from EGP 64.11 million for the same period of the previous year.
